The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer

Objective: The use of extraperitoneal surgical staging prior to treatment in patients with bulky or locally advanced cervical cancer allows the detection and treatment of disease beyond the standard pelvic radiation fields. This study was conducted to evaluate the impact of extraperitoneal surgical staging in the treatment and outcome of patients with locally advanced cervical cancer.

Methods: 51 patients with locally advanced cervical cancer treated between 1985 and 1998 were retrospectively reviewed. Information on morbidity, usefulness, and results of surgery and patterns of disease recurrence were obtained. Survival distributions were calculated by the Kaplan-Meier product limit method and compared with the log-rank test.

Results: All 51 women were surgically staged by an extra-peritoneal approach. Preoperative CT scans (n=27) when compared with surgical findings showed sensitivity for pelvic and para-aortic lymph node metastasis of 39%, specificity of 88%, positive predictive value of 39% and negative predictive value of 88%. Lymph node metastases were found in 30/51 patients (59%). There were no significant treatment delays or surgical morbidity as a result of extra-peritoneal surgical staging. In 21 patients (41%), the highest level of involved nodes was in the pelvis and they were treated with pelvic radiation. The para-aortic nodes were involved in nine patients (18%) and were treated with extended field radiation. All patients also received concurrent radiosensitization with chemotherapy. The estimated survival for the entire group was 60% at 5 years. For node negative patients, estimated 5-year survival was 67% while it was 54% for all node positive patients (p=0.17). Analysis according to anatomic site of involved nodes showed that the estimated 2-year and 5-year survival for those with pelvic nodal involvement was 81% and 64%, respectively. However, in the group of nine patients with para-aortic nodal disease, the estimated 2-year survival was 44%. Five (56%) were dead of disease with a median time to death of 16.0 months and four patients (44%) were alive with a median duration of follow up of 16.1 months. There was a statistically significant difference in survival for the group of patients with positive pelvic nodes only compared to the group with positive para-aortic nodes (p=0.03). The estimated 5-year survival by FIGO stage was 80%, 70% and 51% for stages Ib, II, III, disease, respectively. Factors that did not significantly affect survival included age, histology and type of chemotherapy.

Conclusions: Pre-therapy extra-peritoneal surgical staging resulted in treatment modification in 18% of patients with locally advanced cervical cancer. The morbidity from surgery and subsequent radiation therapy was acceptable. The procedure is recommended to allow for individualization of treatment in patients with local-regional cervical cancer.

Extraperitoneal; Surgical staging; Cervical cancer; Extended field radiation; Para-aortic nodes

[1] Parkin D. M., Laura E., Muir C. S.: "Estimates of the worldwide frequency of sixteen major cancers in 1980". Int. J. Cancer, 1988, 41, 184.

[2] LaPolla J. P., Schlaerth J. B., Gaddis 0., Morrow C. P.: " The influence of surgical staging on the evaluation and treatment of patients with cervical carcinoma". Gynecol. Oneal., 1986, 24, 194.

[3] Ballon S. C., Berman M. L., Legasse L. D., Petrilli E. S., Castaldo T. W.: "Survival after extraperitoneal pelvic and para-aortic lymphadenectomy and radiation therapy in cervical carcinoma". Obstet. Gynecol., 1981, 57, 90.

[4] Kosary C. L.: "FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecologic system: an analysis of the 1973-87 SEER cases of cancer of the endometrium, cervix, ovary, vulva, and vagina". Semin. Surg. Oneal., 1994, 10, 31.

[5] Chung C. K., Nahhas W. A., Stryker J. A., Curry S. L., Abt A. B., Mortel R.: "Analysis of factors contributing to treatment failures in stages 1B and IIA carcinoma of the cervix". Am. J. Obstet. Gynecol., 1980, 138, 550.

[6] Burghardt E., Monaghan J. M.: "Management decision-making using clinical and operative staging in cervical cancer". Ballieres Clinical Obstetrics and Gynecology, 1989.

[7] Rotman M., Pajak T. F., Choi K., Clery M., Marcial V., Grisby P. W. et al.: "Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky 1B and IIA cervical carcinomas: tenyear treatment results of RTOG 79-20". Jama, 1995, 274, 387.

[8] Carl U. M., Bahnsen J., Wiegel T.: "Radiation therapy of paraaortic lymph nodes in cancer of the uterine cervix". Acta Oneal., 1993, 32, 63.

[9] Greer B. E., Koh W. J., Stelzer K. J., Goff B. A., Comsia N., Tran A.: "Expanded pelvic radiotherapy fields for treatment of localregionally advanced carcinoma of the cervix: outcome and complications". Am. J. Obstet. Gynecol., 1996, 174, 1141.

[10] Malfetano J. H.,K eys H.,C unningham M. J.,G ibbons S.,A mbros R.: "Extended field radiation and cisplatin for stage IIB and IIIB cervical carcinoma". Obstet. Gynecol., 1997, 67, 203.

[11] Keys H. M., Bundy B. N., Stehman F. B., Muderspach L. I., Chafe W. E., Suggs C. L., Walker J. L., Gersell D.: "Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage 1B cervical carcinoma". N. Engl. J. Med., 1999, 340, 1154.

[12] Rose P. G., Bundy B. N., Watkins E. B., Thigpen J. T., Deppe G., Maiman M. A. et al.: "Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer". N. Engl. J. Med., 1999, 340, 1144.

[13] Russel A. H., Shingleton H. M., Jones W. B. et al.: "Diagnostic assessment in patients with invasive cancer of the cervix: a national patterns of care study of the American College of Surgeons". Gynecol. Oneal., 1996, 63, 159.

[14] Rotman M., Choi K., Guze C., Marcial V., Hornback N., John M.: "Prophylactic irradiation of the para-aortic lymph node chain in stage IIB and bulky stage 1B carcinoma of the cervix,i nitial treatment results of RTOG 79-20". Int. J. Radial. Oneal. Biol. Phys., 1990, 19, 513.

[15] Haie C., Pejovic M., Gerbaulet A., Horiot J., Porquier H., Delouche J. et al.: "Is prohylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group". Radiother. Oneal., 1988, 11, 101.

[16] Cosin J. A., Fowler J. M., Chen M. D., Paley P. J., Carson L. F., Twiggs L. B.: "Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking". Cancer, 1998, 82, 2241.

[17] Kim P. Y.,M onk B. J.,S anj ay C. B. S. et al.: "Cervical cancer with para-aortic metastasis: significance of residual para-aortic disease after surgical staging". Gynecol. Oneal., 1998, 69, 243.

[18] Hacker N. F., Wain G. V., Nicklin J. L.: "Resection of bulky positive lymph nodes in patients with cervical carcinoma". Int. J. Gynecol. Cancer, 1995, 5, 250.

[19] Berman M. L., Lagasse L. D., Watring W. G. et al.: "The operative evaluation of patients with cervical carcinoma by an extraperitoneal approach". Obstetrics and Gynecology, 1997, 50, 658.

[20] Kaplan E. L., Meier P.: "Nonparametric estimation from incomplete observations". J. Am. Stat. Assoc., 1958, 53, 457.

[21] Cox D. R.: "Regression models and life - tables". J. Royal Stat. Soc., 1972, 34, 187.

[22] Berman M. L., Keys H. M., Creasman W. T., DiSaia P. J., Blessing J., Bundy B.: "Survival and patterns of recurrence in cervical cancer metastatic to peraortic lymph nodes". Gynecol. Oncol., 1984, 19, 198.

[23] Heller P. B., Malfetano J. H., Bundy B. N., Barnhill D. R., Okagaki T.: "Clinicalpathologic study of stage IIB, III, and IV A carcinoma of the cervix: extended diagnostic evaluation for paraortic node metastasis - a Gynecologic Oncology Group study". Gynecol. Oncol., 1990, 38, 425.

[24] Morris M.,E ifel P. J.,L u J.,G rigsby P. W.,L evenback C.,S tevens R. E. et al.: "Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer". N. Engl. J. Med., 1999, 340, 1137.

[25] Ebner F., Tamussino K., Kressel H. Y.: "Magnetic resonance imagin in cervical carcinoma: diagnosis, staging and follow－up＂ ．Magnetic Resonance, 1994, 10, 22.

[26] Rose P. G., Adler L. P., Rodriguez M., Faulhaber P. F., AbdulKarim F. W., Miraldi, F.: "Positrom emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study". J. Clin. Oncol., 1999, 17, 41.

[27] Komaki R., Brickner T. H., Hanlon A. L., Ower J. B.,H anks G. E.: "Long term results of treatment of cervical carcinoma in the United States in 1973, 1978 and 1983: Patterns of Care Study (PCS)". Int. J. Radiat. Oncol. Biol. Phys., 1995, 31, 973.

[28] Goff B. A., Muntz H. G., Paley P. J., Tamimi H. K., Koh W.-J., Greer B. E.: "Impact of surgical staging in women with locally advanced cervical cancer". Gynecol. Oncol., 1999, 74, 436.

[29] Varia M. A., Bundy B. N., Deppe G. et al.: "Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: A Gynecologic Oncology Group Study". Int. J. Radiat. Oncol. Biol. Phys., 1998, 42, 1015.

[30] Jolles C. J., Freedman R. S., Hamberger A. D., Horbelt D. V.: "Complications of extended-field therapy for cervical carcinoma without prior surgery". Int. J. Radiat. Oncol. Biol. Phys., 1986, 12, 179.

[31] Piver M. S., Lele S. B., Malfetano J. H.: "Cis-diarnminedichloroplatinum II based combination chemotherapy for the control of extensive paraaortic lymph node metastasis in cervical cancer". Gynecol. Oncol., 1987, 26, 71.

[32] F letcher G. H.: "Subclinical disease". Cancer, 1984, 53, 1274.

[33] Fine B. A., Hempling R. E., Piver M. S., Baker T. R., McAuley M., Driscoll D.: "Severe radiation morbidity in carcinoma of the cervix: impact of pretherapy surgical staging and previous surgery". Int. J. Radiat. Oncol. Biol. Phys.,1995, 31, 717.

[34] Weiser E. B., Bundy B. N., Hos灼ns W. J. et al.: "Extraperitoneal vs. transperitoneal selective paraaortic lymphadenectomy in the pretreatment surgical staging of advanced cervical carcinoma (A Gynecologic Oncology Group Study)". Gynecol. Oncol., 1989, 33, 283.

[35] Chen M. D., Teigen G. A., Reynold H. T. et al.: "Laparoscopy versus laparotomy: an evaluation of adhesion formation after pelvic and para-aortic lymphadenectomy in a porcine model". Am. J. Obstet., 1998, 178, 499.